Filing Details
- Accession Number:
- 0001209191-21-002840
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-08 21:08:09
- Reporting Period:
- 2021-01-07
- Accepted Time:
- 2021-01-08 21:08:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1595893 | Turning Point Therapeutics Inc. | TPTX | Pharmaceutical Preparations (2834) | 463826166 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1772399 | Lee Brian Baker | C/O Turning Point Therapeutics, Inc. 10628 Science Center Drive, Ste. 200 San Diego CA 92121 | Svp Of Finance And Admin. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-01-07 | 11,905 | $2.19 | 15,713 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-01-07 | 1,299 | $3.20 | 17,012 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-01-07 | 4,545 | $5.12 | 21,557 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-01-07 | 10,689 | $7.43 | 32,246 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-07 | 2,800 | $122.65 | 29,446 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-07 | 900 | $120.16 | 28,546 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-07 | 5,200 | $121.57 | 23,346 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-07 | 21,825 | $122.44 | 1,521 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-07 | 513 | $123.02 | 1,008 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-01-07 | 11,905 | $0.00 | 11,905 | $2.19 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-01-07 | 1,299 | $0.00 | 1,299 | $3.20 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-01-07 | 4,545 | $0.00 | 4,545 | $5.12 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-01-07 | 10,689 | $0.00 | 10,689 | $7.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,069 | 2027-08-08 | No | 4 | M | Direct | |
| 1,298 | 2028-03-08 | No | 4 | M | Direct | |
| 11,039 | 2028-11-05 | No | 4 | M | Direct | |
| 30,356 | 2029-02-19 | No | 4 | M | Direct |
Footnotes
- Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 16, 2020.
- The Reporting Person acquired 365 shares on June 12, 2020 pursuant to the Issuer's Employee Stock Purchase Plan (the "ESPP") and 427 shares on December 10, 2020 pursuant the ESPP.
- The weighted average sale price for the transaction reported was $122.65, and the range of prices were between $122.50 and $123.00. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $120.16, and the range of prices were between $119.90 and $120.68. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $121.57, and the range of prices were between $120.96 and $121.96. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $122.44, and the range of prices were between $121.97 and $122.76. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $123.02, and the range of prices were between $122.98 and $123.69. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- One-fourth of the option vested on July 6, 2018. Thereafter, 1/48th of the Option vests on a monthly basis over 36 months until the option becomes fully vested.
- Vests in 36 equal successive monthly installments on each monthly anniversary of January 1, 2018.
- 1/48th of the shares vest monthly following November 6, 2018.
- 25% of the shares vest on February 12, 2020 and 1/48th of the shares vest monthly thereafter over the next three years.
Billionaire Hedge Funds
